Joan Priddy Southern
Adult Health · Winston Salem, NCNPI 1427356153
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,026, 5.7 times the $181 reported in 2021.
Across 127 payments — averaging $23.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$520
- Collegium Pharmaceutical, Inc.$372
- AbbVie$261
- Boston Scientific$252
- SPR Therapeutics, Inc$250
- Nalu Medical, Inc.$189
- plus $1K from 17 others
Across 1 payment — averaging $10,064 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Arthrex$10K
What the payments were for
- Food & beverage$2,96899%
- Education$181%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 25 | $520 |
| Collegium Pharmaceutical, Inc. | 17 | $372 |
| AbbVie | 16 | $261 |
| Boston Scientific | 13 | $252 |
| SPR Therapeutics, Inc | 7 | $250 |
| Nalu Medical, Inc. | 4 | $189 |
| Painteq LLC | 2 | $179 |
| Vertex | 6 | $162 |
| Nevro Corp. | 3 | $160 |
| Pfizer | 8 | $121 |
| Virtus Pharmaceuticals LLC | 4 | $80 |
| Saluda Medical Americas, Inc. | 1 | $73 |
| Scilex Pharmaceuticals Inc. | 4 | $64 |
| Redhill Biopharma Inc. | 3 | $61 |
| IBSA Pharma Inc. | 3 | $52 |
| Medtronic | 2 | $41 |
| Azurity Pharmaceuticals, Inc. | 2 | $35 |
| Tersera Therapeutics LLC | 1 | $35 |
| Hikma Pharmaceuticals USA | 1 | $19 |
| Averitas Pharma Inc. | 1 | $18 |
| Almatica Pharma LLC | 1 | $14 |
| Biodelivery Sciences International, Inc. | 1 | $14 |
| GRT US Holding, Inc. | 2 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,986 in reported general payments places this provider in the 85th percentile of 614 adult health providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 101 | $132,455 |
| NucyntaTapentadol Hcl | 54 | $58,993 |
| Nucynta ErTapentadol Hcl | 35 | $54,437 |
| Buprenorphine | 135 | $43,755 |
| Xtampza ErOxycodone Myristate | 56 | $43,590 |
| BelbucaBuprenorphine Hcl | 56 | $39,548 |
| Oxymorphone Hcl ErOxymorphone Hcl | 13 | $31,413 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 602 | $22,909 |
| LinzessLinaclotide | 29 | $20,915 |
| ZtlidoLidocaine | 24 | $19,480 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 453 | $16,357 |
| Morphine Sulfate ErMorphine Sulfate | 265 | $13,002 |
| Gabapentin | 303 | $10,288 |
| Lidocaine | 49 | $7,681 |
| Fentanyl | 79 | $7,502 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta, Nucynta Er, Xtampza Er, Belbuca | $372 | $196,568201 claims |
| Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate, Buprenorphine Hcl | $19 | $48,921290 claims |
| AbbVieLinzess | $261 | $20,91529 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $64 | $19,48024 claims |
| Redhill Biopharma Inc.Movantik | $61 | $7,31712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 614 adult health providers in North Carolina.
Other adult health in Winston Salem
- Aruna HulmeWinston Salem$17K
- Robert DodgeRaleigh$311K
- Kimberly CampDurham$147K
- Henry VanpalaRaleigh$110K
- Jolene SpencerWashington$83K
- Felicia RichardsonGreenville$64K
- Anna BooneReidsville$51K
- Chaely MedleyChapel Hill$47K
- Ann ShumDurham$35K
- Amy HopkinsGreenville$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.